Related references
Note: Only part of the references are listed.Screening for Colorectal Cancer: A Guidance Statement From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2012)
CDDO-Methyl Ester Delays Breast Cancer Development in Brca1-Mutated Mice
Eun-Hee Kim et al.
CANCER PREVENTION RESEARCH (2012)
Tumor-associated neutrophils: friend or foe?
Zvi G. Fridlender et al.
CARCINOGENESIS (2012)
Phase II Study of Bevacizumab and Chemoradiation in the Preoperative or Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
David R. Spigel et al.
CLINICAL COLORECTAL CANCER (2012)
Preferred therapies for neovascular age-related macular degeneration
David R. Lally et al.
CURRENT OPINION IN OPHTHALMOLOGY (2012)
Targeting mTOR Pathways in Human Malignancies
Angelica Fasolo et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway
Sylvie Lamy et al.
EXPERIMENTAL CELL RESEARCH (2012)
Angiopoietin2 and Tie2: Tied to Lymphangiogenesis and Lung Metastasis. New Perspectives in Antimetastatic Antiangiogenic Therapy
Adriana Albini et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Antiangiogenic therapy-evolving view based on clinical trial results
Gordon C. Jayson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis
Sofia Konisti et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents
Mario Siervo et al.
NUTRITION (2012)
Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry
Ilaria Sogno et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
Effects of catechin-enriched green tea beverage on visceral fat loss in adults with a high proportion of visceral fat: A double-blind, placebo-controlled, randomized trial
Ying Zhang et al.
JOURNAL OF FUNCTIONAL FOODS (2012)
Effects of Antioxidant Components of AREDS Vitamins and Zinc Ions on Endothelial Cell Activation: Implications for Macular Degeneration
Shemin Zeng et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Extended results of the Alzheimer's disease anti-inflammatory prevention trial
John C. Breitner et al.
ALZHEIMERS & DEMENTIA (2011)
Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis
Elisabeth M. Battinelli et al.
BLOOD (2011)
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
Pamela J. Goodwin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Curcumin A component of the golden spice, targets multiple angiogenic pathways
Vivek R. Yadav et al.
CANCER BIOLOGY & THERAPY (2011)
C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment
Andrew T. Chan et al.
CANCER PREVENTION RESEARCH (2011)
Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases-Safety, Pharmacokinetics, and Pharmacodynamics
Lynne M. Howells et al.
CANCER PREVENTION RESEARCH (2011)
Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
Robert E. Carroll et al.
CANCER PREVENTION RESEARCH (2011)
Tamoxifen, Flaxseed, and the Lignan Enterolactone Increase Stroma- and Cancer Cell-Derived IL-1Ra and Decrease Tumor Angiogenesis in Estrogen-Dependent Breast Cancer
Gabriel Lindahl et al.
CANCER RESEARCH (2011)
Caloric restriction reduces growth of mammary tumors and metastases
Mariana S. De Lorenzo et al.
CARCINOGENESIS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
Diet-Derived Phytochemicals: From Cancer Chemoprevention to Cardio-Oncological Prevention
N. Ferrari et al.
CURRENT DRUG TARGETS (2011)
Resveratrol, a Phytochemical Inducer of Multiple Cell Death Pathways: Apoptosis, Autophagy and Mitotic Catastrophe
D. Delmas et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Cancer Stem Cells and the Tumor Microenvironment: Soloists or Choral Singers
A. Albini et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Vascular Endothelial Growth Factor Haplotypes Associated with Childhood Obesity
Vanessa A. Belo et al.
DNA AND CELL BIOLOGY (2011)
Epigenetic changes induced by curcumin and other natural compounds
Simone Reuter et al.
GENES AND NUTRITION (2011)
Polyphenolics from Acai (Euterpe oleracea Mart.) and Red Muscadine Grape (Vitis rotundifolia) Protect Human Umbilical Vascular Endothelial Cells (HUVEC) from Glucose- and Lipopolysaccharide (LPS)-Induced Inflammation and Target MicroRNA-126
Giuliana D. Noratto et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Projections of the Cost of Cancer Care in the United States: 2010-2020
Angela B. Mariotto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn et al.
LANCET (2011)
Preventive therapy for breast cancer: a consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
DESIGNING SMARTER CANCER PREVENTION TRIALS
Erika Jonietz
NATURE (2011)
LIFESTYLE Breaking the cancer habit
Cassandra Willyard
NATURE (2011)
PERSPECTIVE The big C - for Chemoprevention
Michael B. Sporn
NATURE (2011)
Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression
Mina J. Bissell et al.
NATURE MEDICINE (2011)
Metastamirs: a stepping stone towards improved cancer management
Nicole M. A. White et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
John M. L. Ebos et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Tamoxifen and Flaxseed Alter Angiogenesis Regulators in Normal Human Breast Tissue In Vivo
Ulrika W. Nilsson Aberg et al.
PLOS ONE (2011)
A Distant Glimpse Of Alien Life?
Yudhijit Bhattacharjee
SCIENCE (2011)
Proteolytic networks in cancer
Steven D. Mason et al.
TRENDS IN CELL BIOLOGY (2011)
Vascular targeting of adipose tissue as an anti-obesity approach
Alexes C. Daquinag et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Infantile Hemangioma-Mechanism(s) of Drug Action on a Vascular Tumor
Shoshana Greenberger et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
The Safety and Efficacy of Celecoxib in Children With Familial Adenomatous Polyposis
Patrick M. Lynch et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Normal ranges of angiogenesis regulatory proteins in human platelets
Jon E. Peterson et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Elusive Identities and Overlapping Phenotypes of Proangiogenic Myeloid Cells in Tumors
Seth B. Coffelt et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The inhibition of autophagy potentiates anti-angiogenic effects of sulforaphane by inducing apoptosis
Takeshi Nishikawa et al.
ANGIOGENESIS (2010)
Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals
Bharat B. Aggarwal
ANNUAL REVIEW OF NUTRITION, VOL 30 (2010)
Metformin inhibits inflammatory angiogenesis in a murine sponge model
D. O. Xavier et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
Subash C. Gupta et al.
CANCER AND METASTASIS REVIEWS (2010)
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
David G. DeNardo et al.
CANCER AND METASTASIS REVIEWS (2010)
Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer
Christina Bendrik et al.
CANCER LETTERS (2010)
Resveratrol Suppresses Colitis and Colon Cancer Associated with Colitis
Xiangli Cui et al.
CANCER PREVENTION RESEARCH (2010)
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria A. Brown et al.
CANCER RESEARCH (2010)
Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research
Stephen D. Hursting et al.
CARCINOGENESIS (2010)
Reference Profile Correlation Reveals Estrogen-like Trancriptional Activity of Curcumin
Beatrice E. Bachmeier et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs
Adriana Albini et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Angioprevention with fenretinide: Targeting angiogenesis in prevention and therapeutic strategies
Ilaria Sogno et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
The 'chemoinvasion' assay, 25 years and still going strong: the use of reconstituted basement membranes to study cell invasion and angiogenesis
Adriana Albini et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Alberto Mantovani et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer
S. Whyte et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Adriana Albini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial
Craig A. Elmets et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG
Palrasu Manikandan et al.
LIFE SCIENCES (2010)
Metronomic chemotherapy: new rationale for new directions
Eddy Pasquier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases
Yihai Cao
NATURE REVIEWS DRUG DISCOVERY (2010)
Antiangiogenic Activity of 2-Deoxy-D-Glucose
Jaime R. Merchan et al.
PLOS ONE (2010)
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ER alpha negative MDA-MB-435 breast cancer model
Kathryn N. Phoenix et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Is it Time to Test Metformin in Breast Cancer Clinical Trials?
Massimiliano Cazzaniga et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Monica M. Bertagnolli et al.
CANCER PREVENTION RESEARCH (2009)
Cancer Prevention: From 1727 to Milestones of the Past 100 Years
Scott M. Lippman et al.
CANCER RESEARCH (2009)
Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1
Bee K. Tan et al.
CARDIOVASCULAR RESEARCH (2009)
Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
Bharat B. Aggarwal et al.
CLINICAL CANCER RESEARCH (2009)
Regulation of Angiogenesis by Oxygen and Metabolism
Peter Fraisl et al.
DEVELOPMENTAL CELL (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide
Soona Shin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals
Francesca Tosetti et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Prospective Evaluation of Whole-Body Cancer Screening With Multiple Modalities Including [18F] Fluorodeoxyglucose Positron Emission Tomography in a Healthy Population: A Preliminary Report
Sadahiko Nishizawa et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Evidence of angiogenic vessels in Alzheimer's disease
Brinda S. Desai et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Bernard F. Cole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Molecular targets for cancer chemoprevention
William N. William et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
MicroRNAs: Opening a New Vein in Angiogenesis Research
Jason E. Fish et al.
SCIENCE SIGNALING (2009)
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
R. E. Harris
INFLAMMOPHARMACOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
Ahmad Aljada et al.
ANGIOGENESIS (2008)
Reactive oxygen species and endothelial activation
Sara P. Alom-Ruiz et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Green Tea Extracts for the Prevention of Metachronous Colorectal Adenomas: A Pilot Study
Masahito Shimizu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions
Susan R. Mallery et al.
CANCER RESEARCH (2008)
Phase II trial of curcumin in patients with advanced pancreatic cancer
Navneet Dhillon et al.
CLINICAL CANCER RESEARCH (2008)
Natural and Synthetic Agents Targeting Inflammation and Angiogenesis for Chemoprevention of Prostate Cancer
Spiridione Garbisa et al.
CURRENT CANCER DRUG TARGETS (2008)
Endothelial Cell Aging and Apoptosis in Prevention and Disease: E-Selectin Expression and Modulation As A Model
Douglas Noonan et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Chemoprevention of human prostate cancer by Green Tea Catechins: Two years later. A follow-up update
Maurizio Brausi et al.
EUROPEAN UROLOGY (2008)
Angiogenesis is regulated by a novel mechanism:: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released
Joseph E. Italiano et al.
BLOOD (2008)
Platelet-associated PF-4 as a biomarker of early tumor growth
David Cervi et al.
BLOOD (2008)
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions
Douglas M. Noonan et al.
CANCER AND METASTASIS REVIEWS (2008)
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent
Nicola Vannini et al.
MOLECULAR CANCER THERAPEUTICS (2007)
IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway
Dung-Fang Lee et al.
CELL (2007)
Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis
Dahlia Lainer-Carr et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
The tumour microenvironment as a target for chemoprevention
Adriana Albini et al.
NATURE REVIEWS CANCER (2007)
Angiogenesis modulates adipogenesis and obesity
Yihai Cao
JOURNAL OF CLINICAL INVESTIGATION (2007)
Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism
Gillian M. Borthwick et al.
FASEB JOURNAL (2006)
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis
Marcia Cruz-Correa et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer
U. Veronesi et al.
ANNALS OF ONCOLOGY (2006)
Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study
S Bettuzzi et al.
CANCER RESEARCH (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
Tumor inflammatory angiogenesis and its chemoprevention
A Albini et al.
CANCER RESEARCH (2005)
Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy
S Gately et al.
SEMINARS IN ONCOLOGY (2004)
Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions
WS Ahn et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2003)
Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males:: An autopsy study
M Sánchez-Chapado et al.
PROSTATE (2003)
Chemopreventive agents induce a senescence-like phenotype in rat mammary tumours
KT Christov et al.
EUROPEAN JOURNAL OF CANCER (2003)
Topically applied imiquimod inhibits vascular tumor growth in vivo
R Sidbury et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Antiangiogenic mechanisms of diet-derived polyphenols
YH Cao et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2002)
'Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents
F Tosetti et al.
FASEB JOURNAL (2002)
Share Paper
